Literature DB >> 23594380

Rhabdomyolysis presenting with severe hypokalemia in hypertensive patients: a case series.

Zhang Wen1, Li Chuanwei, Zeng Chunyu, Huang Hui, Li Weimin.   

Abstract

BACKGROUND: Rhabdomyolysis presenting with severe hypokalemia as the first manifestation of primary hyperaldosteronism is extremely rare. CASE
PRESENTATION: Two middle-aged Chinese females were admitted to our emergency department for muscular weakness and limb pain, and both have the history of early onset hypertension. Laboratory test showed elevated creatinine phosphokinase (4, 907 and 8, 531 IU/L) and extremely low serum potassium (1.38 mmol/L and 1.98 mmol/L). Rhabdomyolysis and severe hypokalemia were established as first diagnosis. Hypokalemic rhabdomyolysis was confirmed after nervous system disorders, autoimmune diseases and trauma were excluded. Adrenal computerized tomography scan and postural stimulation test revealed aldosterone-producing adenomas. They both received laparoscopic adrenalectomy and were stable at the 2-year follow-up visit.
CONCLUSION: The two cases remind physicians to bear in mind the risk of hypokalemia-induced rhabdomyolysis among patients with primary hyperaldosteronism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23594380      PMCID: PMC3637555          DOI: 10.1186/1756-0500-6-155

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


Background

Primary hyperaldosteronism (PHA) is a common cause of secondary hypertension. The main clinical manifestations are resistant hypertension and hypokalemia. Hypokalemia induced by PHA is a chronic process and most patients can tolerant the symptoms of malaise, muscular weakness and fatigability. But in some extreme conditions, PHA can induce excessive potassium excretion followed by rhabdomyolysis. Rhabdomyolysis presenting with severe hypokalemia as the first manifestation is rare in primary hyperaldosteronism. We report two cases of PHA diagnosed successfully.

Case presentation

Case 1

A 45-year-old Chinese female presented herself with fatigue and limb pain since 10 days in the emergency department. A slight pain in the right femoribus internus gradually aggravated in severity and extent during the following 10 days, and progressively got the upper limbs, back and neck involved in. She reported about a four-year history of arterial hypertension treated with nitrendipine and captopril. She denied any acute infections, trauma or intoxication. Physical examination revealed slightly elevated blood pressure (143/80 mmHg) and tenderness in the limb muscles. The laboratory examinations (Table 1) showed extremely low serum potassium (1.38 mmol/L) and elevated CPK (4, 907 IU/L). Electrocardiogram (ECG) showed Q-T interval elongation and abnormal U wave.
Table 1

Laboratory data on admission

 Case 1Case 2
Urinalysis
 
pH
8.00
7.00
glucose
-
-
protein
-
-
ketone
-
-
CBC
 
WBC
11.40 × 109/L
8.38 × 109/L
RBC
4.71 × 1012/L
4.68 × 1012/L
Hb
129 g/L
139 g/L
Hct
0.39 L/L
0.39 L/L
Plt
158 × 109/L
255 × 109/L
Blood Chemistry
 
Alb
47.1 g/L
37.4 g/L
TBIL
17.0 umol/L
13.8 umol/L
ALT
61 IU/L
46 IU/L
AST
123 IU/L
115 IU/L
GLU
6.56 mmol/L
5.33 mmol/L
BUN
7.15 mmol/L
2.69 mmol/L
Cre
92.7 umol/L
58.8 umol/L
UA
297.5 umol/L
176.0 umol/L
Myo
28.28 ng/ml
 
CHOL
4.56 mmol/L
4.00 mmol/L
TG
1.63 mmol/L
2.94 mmol/L
HDL-C
1.56 mmol/L
0.83 mmol/L
CK
4907 IU/L
8531 IU/L
LDH
477 IU/L
335 IU/L
Na
142.1 mmol/L
146.0 mmol/L
K
1.38 mmol/L
1.98 mmol/L
Cl
98.7 mmol/L
97.8 mmol/L
Arterial Blood Gas Analysis on Room Air
 pH
7.432
7.487
pO2
72.0 mmHg
75.2 mmHg
pCO2
37.4 mmHg
43.1 mmHg
HCO3-
24.4 mmol/L
31.9 mmol/L
BE0.4 mmol/Lmmol/L
Laboratory data on admission Based upon these clinical features, we established hypokalemia and rhabdomyolysis as first diagnosis. A series of laboratory examinations were performed for differential diagnosis of rhabdomyolysis. Biopsy results of right biceps brachii muscle revealed degenerated and necrotic muscle fibers with some inflammatory cells infiltrating the perimysium. The electromyogram was normal, which excluded nervous system disorders. Rhabdomyolysis induced by autoimmune diseases were excluded for negative results of autoimmune antibodies. Hence, we supposed hypokalemia induces rhabdomyolysis. Tests for synchronous serum and urine potassium (First time: serum potassium 3.10 mmol/L, urine potassium 57.98 mmol/24 h; Second time: serum potassium 2.87 mmol/L, urine potassium 48.63 mmol/24 h) illustrated excessive potassium loss. Normal pH in arterial blood eliminated the suspect of renal tubule diseases. High dose oral potassium supplementation was initiated. Pain and weakness were relieved and serum CPK levels normalized within one week. However, the serum potassium level remained low (3.00 mmol/L) despite potassium supplementation. Increased Aldosterone to Renin ration (ARR) indicated PHA (See Table 2 and Figure 1). Adrenal imaging with computerized tomography (CT) scan showed a low-density mass measuring 2.1 cm in diameter in the left adrenal (Figure 2). After initiation of spironolactone treatment, blood pressure and potassium levels in serum and urine returned to normal within one week.
Table 2

Endocrine test results

 Case 1Case 2Reference range 
Basal endocrine data: before postural stimulation test
PRA
0.84
0.07
0.05-0.84
ng/ml.h
AT-II
28.61
43.63
28.2-52.2
ng/L
PAC
639.38
449.70
45-175
ng/L
ARR
76.12
642.43
 
ng/dl:ng
NE
<50
59
174-357
ng/L
E
<50
<25
60-104
ng/L
TSH
4.180
6.360
0.27-4.2
mU/L
T3
2.21
 
1.3-3.1
nmol/L
T4
129.30
 
62-164
nmol/L
FT3
 
4.42
3.60-7.50
pmol/L
FT4
 
17.59
12.0-22.0
pmol/L
Endocrine data: 2 hours after postural stimulation test
PRA
 
0.17
0.56-2.79
ng/ml.h
AT-II
 
49.54
29.0-71.6
ng/L
PAC 265.8098-275ng/L
Figure 1

Adrenal imaging of case 1. Nodular mass (diameter approximately 21 mm) on the left adrenal gland, and the right adrenal gland appears normal.

Figure 2

Adrenal histology of case 1. Fine connective tissue septa separate adrenal cortical clear cells nodules and the histopathology of resected specimen shows adenoma (HE × 100 and HE × 400).

Adrenal imaging of case 1. Nodular mass (diameter approximately 21 mm) on the left adrenal gland, and the right adrenal gland appears normal. Adrenal histology of case 1. Fine connective tissue septa separate adrenal cortical clear cells nodules and the histopathology of resected specimen shows adenoma (HE × 100 and HE × 400). Endocrine test results

Case 2

Another Chinese female with 44 years old was admitted to our hospital with similar symptoms and signs of fatigue and limbs pain. Serum potassium was 1.98 mmol/L with highly elevated serum CPK levels (8, 531 IU/L). ECG showed highly elongated Q-T interval and abnormal apparent U wave. Differential work-up for hypokalemia and rhabdomyolysis showed PHA was the diagnosis (see Table 2 and Figure 1). CT scan revealed an adrenal gland mass with 1.6 cm in diameter (Figure 3). Symptoms were relieved after treatment with potassium and spironolactone.
Figure 3

Adrenal imaging of case 2. Nodular mass (diameter approximately 16 mm) on the left adrenal gland.

Adrenal imaging of case 2. Nodular mass (diameter approximately 16 mm) on the left adrenal gland. Both patients were treated with laparoscopic left adrenalectomy. Postural stimulation test and adrenal histology showed aldosterone-producing adenomas (Table 2 and Figure 4). Until the two year follow-up visit, the patients did not complain about similar symptoms anymore, and the blood pressures and potassium levels remained in a normal range.
Figure 4

Adrenal histology of case 2. Adrenal cortical clear cells nodules is around by fine connective tissue septa and the histopathology of resected specimen shows adenoma (HE × 100 and HE × 400).

Adrenal histology of case 2. Adrenal cortical clear cells nodules is around by fine connective tissue septa and the histopathology of resected specimen shows adenoma (HE × 100 and HE × 400).

Discussion

Rhabdomyolysis is defined as a pathological condition of skeletal muscle cell damage leading to the release of toxic intracellular material into the blood circulation, such as CPK, myoglobin, aspartate aminotransferase, alanine aminotransferase and potassium [1-3]. The syndrome generally presents with the triad muscular pain, weakness and reddish brown urine [4]. The major causes of rhabdomyolysis include trauma, ischemia, drugs, toxins, metabolic disorders, infections and electrolyte disorders [5,6]. Especially, severe hypokalemia might play an important role in muscle cell damage [7,8]. Local potassium levels in capillaries are important regulators for vascular tension. Severe hypokalemia contracted capillaries, reduced muscle blood supply and finally resulting in lysing muscle cells and muscle cell damage [9,10]. Frank rhabdomyolysis usually occurs only when serum potassium values are below 2.0 mmol/L [8,11], which possibly induces cardiac arrhythmia and needs emergency treatment. In PHA, aldosterone excess leads to water-sodium retention and potassium excretion. Patients usually present with hypertension and mild hypokalemia, while malaise and muscular weakness is always tolerable for patients. When vomiting or diarrhea occur or diuretics are used, serum potassium levels might drop to very low levels [12]. Although rhabdomyolysis usually results in hyperkalemia due to the direct release of intracellular potassium into the extracellular fluid, over-excreted aldosterone in PHA induces potassium excretion into urine. These mechanisms might be the reason we find hypokalemia, instead of hyperkalemia, resulting from rhabdomyolysis in those two cases.

Conclusion

The diagnosis of PHA might be difficult when rhabdomyolysis and severe hypokalemia are the first manifestation. However, when rhabdomyolysis and hypokalemia occur in hypertensive patients, PHA should be considered. Further investigation for PHA should be initiated.

Consent

Written informed consent was obtained from the patients for publication of this manuscript and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

LW was primarily responsible for the conception, design and revision of the manuscript. ZW drafted the manuscript and searched the literature. ZC was responsible for manuscript editing and advice on literature review. HH was actively involved in the patients’ management and revised the manuscript. LC made substantial contributions to the acquisition of data. All authors read and approved the final manuscript.
  12 in total

Review 1.  Biochemical investigation of suspected rhabdomyolysis.

Authors:  R Beetham
Journal:  Ann Clin Biochem       Date:  2000-09       Impact factor: 2.057

Review 2.  Rhabdomyolysis.

Authors:  Raymond Vanholder; Mehmet Sükrü Sever; Ekrem Erek; Norbert Lameire
Journal:  J Am Soc Nephrol       Date:  2000-08       Impact factor: 10.121

3.  Rhabdomyolysis as a potential complication of carbamazepine-induced toxic epidermal necrolysis.

Authors:  Li-Yen Huang; Chih-Ming Lin; Chien-Chun Chiou; Wei-Shiang Lin; Shu-Meng Cheng
Journal:  Clin Biochem       Date:  2012-06-21       Impact factor: 3.281

Review 4.  Rhabdomyolysis.

Authors:  D Singh; V Chander; K Chopra
Journal:  Methods Find Exp Clin Pharmacol       Date:  2005 Jan-Feb

5.  Hypokalaemia and paralysis.

Authors:  S-H Lin; M R Davids; M L Halperin
Journal:  QJM       Date:  2003-02

Review 6.  Rhabdomyolysis: a review.

Authors:  Jason D Warren; Peter C Blumbergs; Philip D Thompson
Journal:  Muscle Nerve       Date:  2002-03       Impact factor: 3.217

7.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

Authors:  Gian Paolo Rossi; Giampaolo Bernini; Chiara Caliumi; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Chiara Ganzaroli; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Mee-Jung Mattarello; Angelica Moretti; Gaetana Palumbo; Gabriele Parenti; Enzo Porteri; Andrea Semplicini; Damiano Rizzoni; Ermanno Rossi; Marco Boscaro; Achille Cesare Pessina; Franco Mantero
Journal:  J Am Coll Cardiol       Date:  2006-11-13       Impact factor: 24.094

8.  Primary aldosteronism associated with severe rhabdomyolysis due to profound hypokalemia.

Authors:  Atsushi Goto; Yoshihiko Takahashi; Miyako Kishimoto; Shigeru Minowada; Hitoshi Aibe; Kanehiro Hasuo; Hiroshi Kajio; Mitsuhiko Noda
Journal:  Intern Med       Date:  2009-02-16       Impact factor: 1.271

Review 9.  The other medical causes of rhabdomyolysis.

Authors:  Ronald C Allison; D Lawrence Bedsole
Journal:  Am J Med Sci       Date:  2003-08       Impact factor: 2.378

Review 10.  Mechanisms of rhabdomyolysis.

Authors:  J P Knochel
Journal:  Curr Opin Rheumatol       Date:  1993-11       Impact factor: 5.006

View more
  6 in total

1.  Sheehan syndrome presenting as acute renal failure: A rare case report from Somalia.

Authors:  Abdisamad Mohamed Adan; Mohamed Osman Omar Jeele; Mohamed Osman Siyad; Abdulkamil Abdullahi Adani; Mohamed Adan Odowa
Journal:  Ann Med Surg (Lond)       Date:  2022-09-13

2.  Ibuprofen-induced renal tubular acidosis-a rare cause of rhabdomyolysis: a case report.

Authors:  Minh Huan Dang; Samuel Wu; Christopher Sia
Journal:  Oxf Med Case Reports       Date:  2016-08-29

3.  Rhabdomyolysis following severe hypokalemia caused by familial hypokalemic periodic paralysis.

Authors:  Young-Lee Jung; Jae-Young Kang
Journal:  World J Clin Cases       Date:  2017-02-16       Impact factor: 1.337

4.  Hypokalemia-Induced Rhabdomyolysis Caused by Adrenal Tumor-Related Primary Aldosteronism: A Report of 2 Cases.

Authors:  Chung-Tso Chen; Yen-Chieh Wang; Chih-Ming Lin
Journal:  Am J Case Rep       Date:  2021-04-10

5.  Hypokalemia-Induced Rhabdomyolysis by Primary Aldosteronism Coexistent With Sporadic Inclusion Body Myositis.

Authors:  Jong Ha Lee; Eunkuk Kim; Suk Chon
Journal:  Ann Rehabil Med       Date:  2015-10-26

6.  Severe hypercalcemia complicating recovery of acute kidney injury due to rhabdomyolysis.

Authors:  Lisa Aimee Hechanova; Seyed-Ali Sadjadi
Journal:  Am J Case Rep       Date:  2014-09-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.